Immediate Impact

1 by Nobel laureates 60 standout
Sub-graph 1 of 24

Citing Papers

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
1 intermediate paper

Works of C. Constantinidis being referenced

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
2012

Author Peers

Author Last Decade Papers Cites
C. Constantinidis 188 95 46 88 12 326
Maurizio Bellina 240 61 42 180 8 339
Einar Brekkan 166 121 26 75 20 367
Annick S. Devos 122 67 31 28 11 337
Noor Kassira 122 156 22 71 13 291
Moon Ki Jo 239 54 11 30 17 314
Ted B. Manny 209 209 13 27 10 368
Brent V. Yanke 242 77 58 50 13 333
J. R. G. BASTABLE 101 190 37 51 17 329
Edmund C.P. Chedgy 244 49 13 51 12 303
Shengfu Chen 36 42 18 86 11 286

All Works

Loading papers...

Rankless by CCL
2026